help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, Y.
Right arrow Articles by Simpson, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, Y.
Right arrow Articles by Simpson, E. R.

Endocrinology, Vol 137, 5739-5742, Copyright © 1996 by Endocrine Society

ARTICLES

Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene

Y Zhao, VR Agarwal, CR Mendelson and ER Simpson
Cecil H. and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center, Dallas, USA.

In the present report, we show that prostaglandin (PG) E2 is the most potent factor which stimulates aromatase expression via cyclic AMP and promoter II. PGE2 acts via EP1 and EP2 receptor subtypes to stimulate both the PKC and PKA pathways. The combined stimulation of both of these pathways results in maximal expression of promoter II-specific CYP19 transcripts. Since PGE2 is a major secretory product both of breast tumor epithelial cells and fibroblasts, as well as of macrophages infiltrating the tumor site, then this could be the mechanism whereby estrogen biosynthesis is stimulated in breast sites adjacent to a tumor, leading in turn to increased growth and development of the tumor itself.


This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson
Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer
Cancer Res., April 1, 2008; 68(7): 2507 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R. Shibuya, T. Suzuki, Y. Miki, K. Yoshida, T. Moriya, K. Ono, J.-i. Akahira, T. Ishida, H. Hirakawa, D. B Evans, et al.
Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast
Endocr. Relat. Cancer, March 1, 2008; 15(1): 113 - 124.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. G. Hudson, G. L. Gierach, F. Modugno, J. Simpson, J. W. Wilson, R. W. Evans, V. G. Vogel, and J. L. Weissfeld
Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 680 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Ishikawa, V. Fencki, E. E. Marsh, P. Yin, D. Chen, Y.-H. Cheng, S. Reisterd, Z. Lin, and S. E. Bulun
CCAAT/Enhancer Binding Protein {beta} Regulates Aromatase Expression via Multiple and Novel Cis-Regulatory Sequences in Uterine Leiomyoma
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 981 - 991.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Subbaramaiah, C. Hudis, S.-H. Chang, T. Hla, and A. J. Dannenberg
EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells: EVIDENCE OF A BRCA1 AND p300 EXCHANGE
J. Biol. Chem., February 8, 2008; 283(6): 3433 - 3444.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. E. Hollingshead, M. G. Borland, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters
Ligand activation of peroxisome proliferator-activated receptor-{beta}/{delta} (PPAR{beta}/{delta}) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms
Carcinogenesis, January 1, 2008; 29(1): 169 - 176.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
Q. Wu, Y. Zhou, L. Chen, J. Shi, C.-Y. Wang, L. Miao, H. Klocker, I. Park, C. Lee, and J. Zhang
Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2
J. Endocrinol., October 1, 2007; 195(1): 89 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun
Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts
Cancer Res., September 15, 2007; 67(18): 8914 - 8922.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Miki, T. Suzuki, C. Tazawa, Y. Yamaguchi, K. Kitada, S. Honma, T. Moriya, H. Hirakawa, D. B. Evans, S.-i. Hayashi, et al.
Aromatase Localization in Human Breast Cancer Tissues: Possible Interactions between Intratumoral Stromal and Parenchymal Cells
Cancer Res., April 15, 2007; 67(8): 3945 - 3954.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Lu, D. Chen, Z. Lin, S. Reierstad, A. M. Trauernicht, T. G. Boyer, and S. E. Bulun
BRCA1 Negatively Regulates the Cancer-Associated Aromatase Promoters I.3 and II in Breast Adipose Fibroblasts and Malignant Epithelial Cells
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4514 - 4519.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. C. Evrard
Estrogen synthesis in the spinal dorsal horn: a new central mechanism for the hormonal regulation of pain.
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R291 - R299.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Subbaramaiah, L. R. Howe, E. R. Port, E. Brogi, J. Fishman, C. H. Liu, T. Hla, C. Hudis, and A. J. Dannenberg
HER-2/neu Status Is a Determinant of Mammary Aromatase Activity In vivo: Evidence for a Cyclooxygenase-2-Dependent Mechanism.
Cancer Res., May 15, 2006; 66(10): 5504 - 5511.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
T. M. Sissung, D. K. Price, A. Sparreboom, and W. D. Figg
Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention
Mol. Cancer Res., March 1, 2006; 4(3): 135 - 150.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Deb, J. Zhou, S. A. Amin, A. G. Imir, M. B. Yilmaz, Z. Lin, and S. E. Bulun
A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts
J. Biol. Chem., February 3, 2006; 281(5): 2585 - 2597.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Watanabe, M. Noda, and S. Nakajin
Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells
J. Endocrinol., January 1, 2006; 188(1): 59 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
E. Attar and S.E. Bulun
Aromatase and other steroidogenic genes in endometriosis: translational aspects
Hum. Reprod. Update, January 1, 2006; 12(1): 49 - 56.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Safi, A. Kovacic, S. Gaillard, Y. Murata, E. R. Simpson, D. P. McDonnell, and C. D. Clyne
Coactivation of Liver Receptor Homologue-1 by Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} on Aromatase Promoter II and Its Inhibition by Activated Retinoid X Receptor Suggest a Novel Target for Breast-Specific Antiestrogen Therapy
Cancer Res., December 15, 2005; 65(24): 11762 - 11770.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T. Suzuki, Y. Miki, Y. Nakamura, T. Moriya, K. Ito, N. Ohuchi, and H. Sasano
Sex steroid-producing enzymes in human breast cancer
Endocr. Relat. Cancer, December 1, 2005; 12(4): 701 - 720.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss
Inflammation and Endometrial Cancer: A Hypothesis
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. F. Bouchard, H. Taniguchi, and R. S. Viger
Protein Kinase A-Dependent Synergism between GATA Factors and the Nuclear Receptor, Liver Receptor Homolog-1, Regulates Human Aromatase (CYP19) PII Promoter Activity in Breast Cancer Cells
Endocrinology, November 1, 2005; 146(11): 4905 - 4916.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al.
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Yamaguchi, H. Takei, K. Suemasu, Y. Kobayashi, M. Kurosumi, N. Harada, and S.-i. Hayashi
Tumor-Stromal Interaction through the Estrogen-Signaling Pathway in Human Breast Cancer
Cancer Res., June 1, 2005; 65(11): 4653 - 4662.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Zeng, M. Yokohira, K. Saoo, H. Takeuchi, Y. Chen, K. Yamakawa, Y. Matsuda, Y. Kakehi, and K. Imaida
Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor
Carcinogenesis, June 1, 2005; 26(6): 1109 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. W. Brueggemeier, J. C. Hackett, and E. S. Diaz-Cruz
Aromatase Inhibitors in the Treatment of Breast Cancer
Endocr. Rev., May 1, 2005; 26(3): 331 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
E. R. Simpson, M. Misso, K. N. Hewitt, R. A. Hill, W. C. Boon, M. E. Jones, A. Kovacic, J. Zhou, and C. D. Clyne
Estrogen--the Good, the Bad, and the Unexpected
Endocr. Rev., May 1, 2005; 26(3): 322 - 330.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. S. Diaz-Cruz, C. L. Shapiro, and R. W. Brueggemeier
Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2563 - 2570.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Geisler and P. E. Lonning
Aromatase Inhibition: Translation into a Successful Therapeutic Approach
Clin. Cancer Res., April 15, 2005; 11(8): 2809 - 2821.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Strasser-Weippl and P. E. Goss
Advances in Adjuvant Hormonal Therapy for Postmenopausal Women
J. Clin. Oncol., March 10, 2005; 23(8): 1751 - 1759.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Muller-Decker, I. Berger, K. Ackermann, V. Ehemann, S. Zoubova, S. Aulmann, W. Pyerin, and G. Furstenberger
Cystic Duct Dilatations and Proliferative Epithelial Lesions in Mouse Mammary Glands upon Keratin 5 Promoter-Driven Overexpression of Cyclooxygenase-2
Am. J. Pathol., February 1, 2005; 166(2): 575 - 584.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zhou, T. Suzuki, A. Kovacic, R. Saito, Y. Miki, T. Ishida, T. Moriya, E. R. Simpson, H. Sasano, and C. D. Clyne
Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer
Cancer Res., January 15, 2005; 65(2): 657 - 663.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. J. Dannenberg, S. M. Lippman, J. R. Mann, K. Subbaramaiah, and R. N. DuBois
Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
J. Clin. Oncol., January 10, 2005; 23(2): 254 - 266.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. Fan, T. Yanase, H. Morinaga, Y.-M. Mu, M. Nomura, T. Okabe, K. Goto, N. Harada, and H. Nawata
Activation of Peroxisome Proliferator-Activated Receptor-{gamma} and Retinoid X Receptor Inhibits Aromatase Transcription via Nuclear Factor-{kappa}B
Endocrinology, January 1, 2005; 146(1): 85 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. R. Bauman, S. I. Rudnick, L. M. Szewczuk, Y. Jin, S. Gopishetty, and T. M. Penning
Development of Nonsteroidal Anti-Inflammatory Drug Analogs and Steroid Carboxylates Selective for Human Aldo-Keto Reductase Isoforms: Potential Antineoplastic Agents That Work Independently of Cyclooxygenase Isozymes
Mol. Pharmacol., January 1, 2005; 67(1): 60 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Miyoshi, S. J. Kim, K. Akazawa, S. Kamigaki, S. Ueda, T. Yanagisawa, T. Inoue, T. Taguchi, Y. Tamaki, and S. Noguchi
Down-Regulation of Intratumoral Aromatase Messenger RNA Levels by Docetaxel in Human Breast Cancers
Clin. Cancer Res., December 15, 2004; 10(24): 8163 - 8169.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Gennari, R. Nuti, and J. P. Bilezikian
Aromatase Activity and Bone Homeostasis in Men
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Stocco
In Vivo and in Vitro Inhibition of cyp19 Gene Expression by Prostaglandin F2{alpha} in Murine Luteal Cells: Implication of GATA-4
Endocrinology, November 1, 2004; 145(11): 4957 - 4966.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Suzuki, Y. Miki, T. Moriya, N. Shimada, T. Ishida, H. Hirakawa, N. Ohuchi, and H. Sasano
Estrogen-Related Receptor {alpha} in Human Breast Carcinoma as a Potent Prognostic Factor
Cancer Res., July 1, 2004; 64(13): 4670 - 4676.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. B. Terry, M. D. Gammon, F. F. Zhang, H. Tawfik, S. L. Teitelbaum, J. A. Britton, K. Subbaramaiah, A. J. Dannenberg, and A. I. Neugut
Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk
JAMA, May 26, 2004; 291(20): 2433 - 2440.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
R. N. DuBois
Aspirin and Breast Cancer Prevention: The Estrogen Connection
JAMA, May 26, 2004; 291(20): 2488 - 2489.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. J. Ellem, J. F. Schmitt, J. S. Pedersen, M. Frydenberg, and G. P. Risbridger
Local Aromatase Expression in Human Prostate Is Altered in Malignancy
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2434 - 2441.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Kovacic, C. J. Speed, E. R. Simpson, and C. D. Clyne
Inhibition of Aromatase Transcription Via Promoter II by Short Heterodimer Partner in Human Preadipocytes
Mol. Endocrinol., January 1, 2004; 18(1): 252 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. J. Ellis
Neoadjuvant Endocrine Therapy as a Drug Development Strategy
Clin. Cancer Res., January 1, 2004; 10(1): 391S - 395S.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. E. Harris, R. T. Chlebowski, R. D. Jackson, D. J. Frid, J. L. Ascenseo, G. Anderson, A. Loar, R. J. Rodabough, E. White, and A. McTiernan
Breast Cancer and Nonsteroidal Anti-Inflammatory Drugs: Prospective Results from the Women's Health Initiative
Cancer Res., September 15, 2003; 63(18): 6096 - 6101.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Pizzagalli, Z. Varga, R. D. Huber, G. Folkers, P. J. Meier, and M. V. St-Pierre
Identification of Steroid Sulfate Transport Processes in the Human Mammary Gland
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3902 - 3912.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. A. Richards and R. W. Brueggemeier
Prostaglandin E2 Regulates Aromatase Activity and Expression in Human Adipose Stromal Cells via Two Distinct Receptor Subtypes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2810 - 2816.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. D. Snyder, U. M. Krishna, J. R. Falck, and A. A. Spector
Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1936 - H1942.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. R. Howe, K. Subbaramaiah, J. Patel, J. L. Masferrer, A. Deora, C. Hudis, H. T. Thaler, W. J. Muller, B. Du, A. M. C. Brown, et al.
Celecoxib, a Selective Cyclooxygenase 2 Inhibitor, Protects against Human Epidermal Growth Factor Receptor 2 (HER-2)/neu-induced Breast Cancer
Cancer Res., October 1, 2002; 62(19): 5405 - 5407.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H.-J. Yang, M. Shozu, K. Murakami, H. Sumitani, T. Segawa, T. Kasai, and M. Inoue
Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3745 - 3753.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson
Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose
Endocrinology, August 1, 2002; 143(8): 2863 - 2871.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Shozu, H. Sumitani, T. Segawa, H.-J. Yang, K. Murakami, T. Kasai, and M. Inoue
Overexpression of Aromatase P450 in Leiomyoma Tissue Is Driven Primarily through Promoter I.4 of the Aromatase P450 Gene (CYP19)
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2540 - 2548.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Davies, L.-A. Martin, N. Sacks, and M. Dowsett
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention
Ann. Onc., May 1, 2002; 13(5): 669 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
J. M. Wallace
Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy
Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37.
[Abstract] [PDF]

Home page
 Recent Prog Horm ResHome page
E. R. Simpson and M. Dowsett
Aromatase and Its Inhibitors: Significance for Breast Cancer Therapy
Recent Prog. Horm. Res., January 1, 2002; 57(1): 317 - 338.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Kawamori, N. Uchiya, S. Nakatsugi, K. Watanabe, S. Ohuchida, H. Yamamoto, T. Maruyama, K. Kondo, T. Sugimura, and K. Wakabayashi
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
Carcinogenesis, December 1, 2001; 22(12): 2001 - 2004.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Cotterchio, N. Kreiger, M. Sloan, and A. Steingart
Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1213 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. R. Simpson and S. R. Davis
Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives
Endocrinology, November 1, 2001; 142(11): 4589 - 4594.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun
Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta}
Cancer Res., March 1, 2001; 61(5): 2328 - 2334.
[Abstract] [Full Text]

Home page
 J Natl Cancer Inst MonogrHome page
C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al.
Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens
J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. E. Harris, G. A. Alshafie, H. Abou-Issa, and K. Seibert
Chemoprevention of Breast Cancer in Rats by Celecoxib, a Cyclooxygenase 2 Inhibitor
Cancer Res., April 1, 2000; 60(8): 2101 - 2103.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. J. Pauley, S. J. Santner, L. R. Tait, R. K. Bright, and R. J. Santen
Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 837 - 846.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
E. Adriaenssens, L. Dumont, S. Lottin, D. Bolle, A. Lepretre, A. Delobelle, F. Bouali, T. Dugimont, J. Coll, and J.-J. Curgy
H19 Overexpression in Breast Adenocarcinoma Stromal Cells Is Associated with Tumor Values and Steroid Receptor Status but Independent of p53 and Ki-67 Expression
Am. J. Pathol., November 1,&n